Aesthetic Medical International Announced Closing of RMB100 Million Private Placement
14 Juillet 2022 - 5:45AM
Aesthetic Medical International Holdings Group Limited (Nasdaq:
AIH) (the “
Company” or “
AIH”), a
leading provider of aesthetic medical services in China, is pleased
to announce that further to its press release on May 31, 2022, the
Company has closed its previously announced private placement
offering through the issuance of 21,413,276 ordinary shares of the
Company (the “
Subscription Shares”) to Hawyu (HK)
Limited at a price of RMB4.67 per Subscription Share for the
aggregate gross proceeds of RMB100 million (the
“
Offering”).
The net proceeds raised from the sale of Shares
under the Offering are expected to be used by the Company for
business expansion, working capital or other purposes as consented
by the investors in accordance with the approved company budget and
business plan.
This press release shall not constitute an offer
to sell or the solicitation of an offer to buy these ordinary
shares, nor shall there be any sale of these ordinary shares in any
state or other jurisdiction in which such offer, solicitation or
sale would be unlawful prior to the registration or qualification
under the securities laws of any such jurisdiction.
The ordinary shares sold in the private
placement have not been registered under the Securities Act of
1933, as amended (the “Securities Act”), or any
state or other applicable jurisdictions’ securities laws, and may
not be offered or sold in the United States absent registration or
an applicable exemption from the registration requirements of the
Securities Act and applicable state or other jurisdictions’
securities laws.
About Aesthetic Medical International
Holdings Group Limited
AIH, known as “Peng’ai” in China, is a leading
provider of aesthetic medical services in China. AIH operates
through treatment centers that spread across major cities in
mainland China, with major focus in the Guangdong-Hong Kong-Macau
Greater Bay area and the Yangtze River Delta area. Leveraging over
20 years of clinical experience, AIH provides one-stop aesthetic
service offerings, including surgical aesthetic treatments,
non-surgical aesthetic treatments, and general medical services and
other aesthetic services. For more information regarding the
Company, please visit: https://ir.aihgroup.net/.
Cautionary Statements
This press release contains “forward-looking
statements.” These statements are made under the “safe harbor”
provisions of the U.S. Private Securities Litigation Reform Act of
1995. These forward-looking statements can be identified by
terminology such as “will”, “expects”, “anticipates”, “aims”,
“future”, “intends”, “plans”, “believes”, “estimates”, “likely to”
and similar statements. Statements that are not historical facts,
including statements about the Company’s beliefs, plans and
expectations, are forward-looking statements. Forward-looking
statements involve inherent risks and uncertainties. These risks
and uncertainties and others that relate to the Company’s business
and financial condition are detailed from time to time in the
Company’s SEC filings, and could cause the actual results to differ
materially from those contained in any forward-looking statement.
These forward-looking statements are made only as of the date
indicated, and the Company undertakes no obligation to update or
revise the information contained in any forward-looking statements,
except as required under applicable law.
Investor Relations Contacts
For investor and media inquiries, please
contact:Aesthetic Medical international Holdings Group
LimitedEmail: ir@pengai.com.cn
DLK Advisory LimitedTel: +852 2857
7101Email: ir@dlkadvisory.com
Aesthetic Medical (NASDAQ:AIH)
Graphique Historique de l'Action
De Mai 2024 à Juin 2024
Aesthetic Medical (NASDAQ:AIH)
Graphique Historique de l'Action
De Juin 2023 à Juin 2024